MASIMasimo Corporation

$9B

Q1 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$340M-39.9% YoY

Gross Profit

$207M60.8% margin

Operating Income

$53M15.6% margin

Net Income

$19M5.6% margin

EPS (Diluted)

$0.35

QoQ Revenue Growth

-38.1%

Cash Flow

Operating Cash Flow

$46M

Free Cash Flow

$35M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$3.0B

Total Liabilities

$1.6B

Stockholders' Equity

$1.4B

Cash & Equivalents

$150M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$340M	$565M	-39.9%
Gross Profit	$207M	$285M	-27.5%
Operating Income	$53M	$38M	+39.7%
Net Income	$19M	$21M	-11.3%

Revenue Segments

Health Care Segment

$340M100%

MASI Q1 2024 Earnings — Masimo Corporation Revenue & Financial Results | Market Cap Arena